Royal Bank of Canada Lowers NeueHealth (NYSE:NEUE) Price Target to $7.00

NeueHealth (NYSE:NEUE) had its target price lowered by stock analysts at Royal Bank of Canada from $8.00 to $7.00 in a report released on Monday,Benzinga reports. The firm presently has a “sector perform” rating on the stock. Royal Bank of Canada’s price objective would suggest a potential upside of 33.59% from the stock’s previous close.

NeueHealth Price Performance

Shares of NEUE stock opened at $5.24 on Monday. The business has a fifty day moving average of $5.23 and a 200 day moving average of $5.32. NeueHealth has a 1 year low of $4.66 and a 1 year high of $16.59. The firm has a market capitalization of $43.39 million, a price-to-earnings ratio of -0.10 and a beta of 0.78.

Institutional Investors Weigh In On NeueHealth

A number of institutional investors and hedge funds have recently modified their holdings of the company. Pathway Capital Management LP purchased a new stake in NeueHealth in the second quarter valued at $61,000. Renaissance Technologies LLC purchased a new stake in shares of NeueHealth in the second quarter worth about $312,000. Partners Group Holding AG acquired a new stake in NeueHealth during the third quarter worth about $463,000. Deer Management Co. LLC acquired a new stake in NeueHealth during the second quarter worth about $5,436,000. Finally, NEA Management Company LLC purchased a new position in NeueHealth during the second quarter valued at approximately $14,834,000. Institutional investors and hedge funds own 63.88% of the company’s stock.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.